Inicio › Enfermedad de obstrucción pulmonar crónica › Carolina del Norte
Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en Carolina del Norte
24 estudios sobre Enfermedad de obstrucción pulmonar crónica buscan participantes en Carolina del Norte.
Ciudades en Carolina del Norte
Texto oficial del estudio (inglés)
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50017, Charlotte
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07725939Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Wake Forest School of Medicine, Salem
Reclutando
Edades de 40 a 80 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07051707WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
- Wake Forest Baptist Medical Center, Winston-Salem
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07558265To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Eximia Research, Raleigh
- Carolina Research Center, Inc., Shelby
ReclutandoFase 2
Edades de 40 a 85 · Todos los sexos · Actualizado el 28 oct 2026 · NCT07684820A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, New Bern
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT07082738Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- East Carolina University- Site Number : 8400102, Greenville
- All-Trials Clinical Research- Site Number : 8400008, Winston-Salem
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07190222A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Charlotte
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07646587A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Salem Chest Specialists, Winston-Salem
- Southeastern Research Center, Winston-Salem
ReclutandoFase 2/3
Edades de 35 a 80 · Todos los sexos · Actualizado el 22 oct 2026 · NCT07363694A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- American Health Research - Charlotte- Site Number : 8400013, Charlotte
- Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400004, Winston-Salem
ReclutandoFase 4
Edades de 40 a 85 · Todos los sexos · Actualizado el 20 oct 2026 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Duke Asthma, Allergy and Airway Center- Site Number : 8400047, Durham
- Advanced Respiratory and Sleep Medicine - Hickory- Site Number : 8400013, Hickory
- Science 37, Llc- Site Number : 8400154, Morrisville
- y 1 más
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 19 oct 2026 · NCT07190209STRIVE Post-Market Registry Study
- Duke University Medical Center, Durham
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 oct 2026 · NCT04302272The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- Duke, Durham
ReclutandoEstudio observacional
Edades de 40 en adelante · Todos los sexos · Actualizado el 15 oct 2026 · NCT07612878A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Charlotte
- Research Site, Concord
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 9 oct 2026 · NCT06878261Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Shelby
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06961214Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, Winston-Salem
- GSK Investigational Site, Winston-Salem
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Greensboro
- Research Site, Greenville
- Research Site, Huntersville
- y 3 más
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 2 oct 2026 · NCT06283966Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
- Southeastern Research Center, Winston-Salem
ReclutandoFase 4
Edades de 60 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT07816835A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, High Point
- Research Site, Kings Mountain
- Research Site, New Bern
- y 1 más
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06883305Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
- Duke Asthma Allergy and Airway Center, Durham
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 27 ago 2026 · NCT07037836Photon-counting CT in Chest Imaging
- Duke University Hospital, Durham
Reclutando
Todas las edades · Todos los sexos · Actualizado el 26 ago 2026 · NCT07031336eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Winston-Salem
ReclutandoFase 3
Edades de 40 a 75 · Todos los sexos · Actualizado el 28 jul 2026 · NCT07177339SPIROMICS Study of Early COPD Progression (SOURCE)
- Wake Forest, Winston-Salem
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 30 a 55 · Todos los sexos · Actualizado el 3 jun 2026 · NCT05033990Pulmonary Hypertension SOLAR
- Duke University Medical Center, Durham
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 feb 2026 · NCT04778046Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Wakemed, Raleigh
ReclutandoEstudio observacional
Edades de 50 en adelante · Todos los sexos · Actualizado el 5 ago 2025 · NCT06122077De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.